Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. Ballantyne CM, Vasas S, Azizad M, Clifton P, et al. N Engl J Med 2024 May 28. doi: 10.1056/NEJMoa2404143.

Read + Share

Amedeo Smart

Independent Medical Education

Ballantyne CM, Vasas S, Azizad M, Clifton P, et al. Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. N Engl J Med 2024 May 28. doi: 10.1056/NEJMoa2404143.
PMID: 38804517